Investors & Media

Corporate News

• July 07, 2020Annovis Bio Receives Institutional Review Board Approval to Initiate 15 Site Phase 2 Study in 68 Parkinson’s and Alzheimer’s Patients
• June 16, 2020Annovis Bio Announces Positive Results from NIH Funded Chronic Toxicology Study
• June 09, 2020Annovis Bio to Present at the June 2020 Virtual Summer Investor Summit

Neurology News

• October 01, 2019Axonal Transport and Neurological Disease
• May 21, 2019How did the amyloid hypothesis go from promising to perilous in the search for Alzheimer’s treatments?
• April 30, 2019After amyloid failures, it’s time to take a new tack for treating Alzheimer’s

MORE NEUROLOGY NEWS